Evidence map›Paper›PMID 25458643›Full record

ReviewAmerican heart journal2014

Metal pollutants and cardiovascular disease: mechanisms and consequences of exposure.

Natalia V Solenkova, Jonathan D Newman, Jeffrey S Berger, George Thurston, Judith S Hochman, Gervasio A Lamas

Abstract readReview
In one paragraph

Review in American heart journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 127 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
127citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

127 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Toxic metal exposure as a possible risk factor for COVID-19 and other respiratory infectious diseases.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2020
    Pooled it
  5. Pooled it
  6. Trial
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

67 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Natalia V SolenkovaDepartment of Medicine, Mount Sinai Medical Center, Miami Beach, FL.
Jonathan D NewmanLeon H Charney Division of Cardiology, New York University School of Medicine, New York, NY.
Jeffrey S BergerLeon H Charney Division of Cardiology, New York University School of Medicine, New York, NY.
George ThurstonNelson Institute of Environmental Medicine, New York University School of Medicine, New York, NY.
Judith S HochmanLeon H Charney Division of Cardiology, New York University School of Medicine, New York, NY.
Gervasio A LamasDepartment of Medicine, Mount Sinai Medical Center, Miami Beach, FL; Columbia University Division of Cardiology at Mount Sinai Medical Center, Miami Beach FL.

Funding

RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI GOLDBERG, JUDITH D. · 1985 to 2020
$26.1M
Trial to Assess Chelation Therapy (TACT)U01AT001156 · NCCIH · MOUNT SINAI MEDICAL CENTER (MIAMI BEACH) · PI LAMAS, GERVASIO A · 2002 to 2004
$18.2M
Institutional Clinical and Translational Science AwardUL1TR000038 · NCATS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CRONSTEIN, BRUCE NEIL · 2012 to 2014
$16.8M
Trial to Assess Chelation Therapy (TACT)U01HL092607 · NHLBI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI LAMAS, GERVASIO A · 2007 to 2012
$13.5M
MODE SELECTION TRIAL IN SINUS NODE DYSFUNCTION (MOST)U01HL049804 · NHLBI · MOUNT SINAI MEDICAL CENTER (MIAMI BEACH) · PI LAMAS, GERVASIO A · 1995 to 2000
$493k
NCATS NIH HHS ULL1TR000038NCCIH NIH HHS U01 AT001156NCCIH NIH HHS U01AT001156NHLBI NIH HHS U01 HL049804NHLBI NIH HHS U01 HL092607NHLBI NIH HHS U01 HL92607NIEHS NIH HHS ES00260NIEHS NIH HHS P30 ES000260
6 · The paper itself

Abstract

introductionThere is epidemiological evidence that metal contaminants may play a role in the development of atherosclerosis and its complications. Moreover, a recent clinical trial of a metal chelator had a surprisingly positive result in reducing cardiovascular events in a secondary prevention population, strengthening the link between metal exposure and cardiovascular disease (CVD). This is, therefore, an opportune moment to review evidence that exposure to metal pollutants, such as arsenic, lead, cadmium, and mercury, is a significant risk factor for CVD.

methodsWe reviewed the English-speaking medical literature to assess and present the epidemiological evidence that 4 metals having no role in the human body (xenobiotic), mercury, lead, cadmium, and arsenic, have epidemiologic and mechanistic links to atherosclerosis and CVD. Moreover, we briefly review how the results of the Trial to Assess Chelation Therapy (TACT) strengthen the link between atherosclerosis and xenobiotic metal contamination in humans.

conclusionsThere is strong evidence that xenobiotic metal contamination is linked to atherosclerotic disease and is a modifiable risk factor.

Indexed as

Cardiovascular DiseasesEnvironmental ExposureArsenicCadmiumChelation TherapyClinical Trials as TopicEnvironmental PollutantsHumansLeadMercuryMetalsRisk FactorsXenobioticsArsenicCadmiumEnvironmental PollutantsLeadMercuryMetalsXenobiotics

Identifiers

PMID25458643
PMCPMC4254412

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.